These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 9313327)

  • 1. Successful treatment of stage-IIIB seminoma with single-agent carboplatin therapy.
    Bohle W; Ruether U; Rassweiler J; Nunnensiek C; Eisenberger F; Jipp P
    Urol Int; 1997; 59(1):53-4. PubMed ID: 9313327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II study: adjuvant single-agent carboplatin therapy for clinical stage I seminoma.
    Krege S; Kalund G; Otto T; Goepel M; Rübben H
    Eur Urol; 1997; 31(4):405-7. PubMed ID: 9187898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retrospective multicentre study of carboplatin monotherapy for clinical stage I seminoma.
    Steiner H; Scheiber K; Berger AP; Rein P; Hobisch A; Aufderklamm J; Pilloni S; Stoehr B; Aigner F; Fritzer A; Zangerl F
    BJU Int; 2011 Apr; 107(7):1074-9. PubMed ID: 21438975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A medical research council randomized trial of single agent carboplatin versus etoposide and cisplatin for advanced metastatic seminoma. MRC Testicular Tumour Working Party.
    Horwich A; Oliver RT; Wilkinson PM; Mead GM; Harland SJ; Cullen MH; Roberts JT; Fossa SD; Dearnaley DP; Lallemand E; Stenning SP;
    Br J Cancer; 2000 Dec; 83(12):1623-9. PubMed ID: 11104556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single agent carboplatin for CS IIA/B testicular seminoma. A phase II study of the German Testicular Cancer Study Group (GTCSG).
    Krege S; Boergermann C; Baschek R; Hinke A; Pottek T; Kliesch S; Dieckmann KP; Albers P; Knutzen B; Weinknecht S; Schmoll HJ; Beyer J; Ruebben H;
    Ann Oncol; 2006 Feb; 17(2):276-80. PubMed ID: 16254023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metastatic seminoma treated with either single agent carboplatin or cisplatin-based combination chemotherapy: a pooled analysis of two randomised trials.
    Bokemeyer C; Kollmannsberger C; Stenning S; Hartmann JT; Horwich A; Clemm C; Gerl A; Meisner C; Rückerl CP; Schmoll HJ; Kanz L; Oliver T
    Br J Cancer; 2004 Aug; 91(4):683-7. PubMed ID: 15266338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carboplatin AUC 10 for IGCCCG good prognosis metastatic seminoma.
    Tookman L; Rashid S; Matakidou A; Phillips M; Wilson P; Ansell W; Jamal-Hanjani M; Chowdhury S; Harland S; Sarwar N; Oliver T; Powles T; Shamash J
    Acta Oncol; 2013 Jun; 52(5):987-93. PubMed ID: 22943385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carboplatin for stage I seminoma.
    Gilligan T; Oh WK; Kantoff PW
    J Clin Oncol; 2006 Jun; 24(18):2971-2; author reply e32-3. PubMed ID: 16782940
    [No Abstract]   [Full Text] [Related]  

  • 9. Long-term experience with carboplatin monotherapy for clinical stage I seminoma: a retrospective single-center study.
    Steiner H; Höltl L; Wirtenberger W; Berger AP; Bartsch G; Hobisch A
    Urology; 2002 Aug; 60(2):324-8. PubMed ID: 12137835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Twelve-year experience with two courses of adjuvant single-agent carboplatin therapy for clinical stage I seminoma.
    Reiter WJ; Brodowicz T; Alavi S; Zielinski CC; Kozak W; Maier U; Nöst G; Lipsky H; Marberger M; Kratzik C
    J Clin Oncol; 2001 Jan; 19(1):101-4. PubMed ID: 11134201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The treatment of stage A testicular seminoma by carboplatin monochemotherapy.
    Bojanić N; Mićić S; Vuksanović A; Vuković I; Janjić A
    Vojnosanit Pregl; 2009 Apr; 66(4):303-6. PubMed ID: 19432296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. One-dose carboplatin in seminoma.
    Oliver T
    Lancet; 2005 Oct 29-Nov 4; 366(9496):1526. PubMed ID: 16257338
    [No Abstract]   [Full Text] [Related]  

  • 13. Carboplatin for stage I seminoma and the sword of Damocles.
    Loehrer PJ; Bosl GJ
    J Clin Oncol; 2005 Dec; 23(34):8566-9. PubMed ID: 16260692
    [No Abstract]   [Full Text] [Related]  

  • 14. Late relapse of stage i seminoma following single-agent carboplatin.
    Raj S; Williams MV; Dixon AK; Robson J; Mazhar D
    Oncology; 2007; 73(5-6):419-21. PubMed ID: 18515983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controversies in the management of stage I seminoma: adjuvant carboplatin revisited.
    Aparicio J; Terrasa J;
    Clin Transl Oncol; 2019 Feb; 21(2):246-247. PubMed ID: 29992462
    [No Abstract]   [Full Text] [Related]  

  • 16. Relapsed seminoma during surveillance: first treatment choice should be radiotherapy.
    Herrera F; Berthold DR
    J Clin Oncol; 2012 Jun; 30(16):2021; author reply 2022. PubMed ID: 22473165
    [No Abstract]   [Full Text] [Related]  

  • 17. Sperm analysis and serum follicle-stimulating hormone levels before and after adjuvant single-agent carboplatin therapy for clinical stage I seminoma.
    Reiter WJ; Kratzik C; Brodowicz T; Haitel A; Pokorny A; Zielinski CC; Marberger M
    Urology; 1998 Jul; 52(1):117-9. PubMed ID: 9671881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treating IIA/B seminoma with combination carboplatin and radiotherapy.
    Gilbert DC; Vanas NJ; Beesley S; Bloomfield D; Money-Kyrle J; Norman A; Dearnaley D; Horwich A; Huddart RA
    J Clin Oncol; 2009 Apr; 27(12):2101-2; author reply 2102-3. PubMed ID: 19289608
    [No Abstract]   [Full Text] [Related]  

  • 19. Carboplatin does not prevent contralateral testicular tumors in patients with seminoma.
    Dieckmann KP; Matthies C; Kliesch S
    J Clin Oncol; 2011 Jul; 29(21):2944-5; author reply 2945-6. PubMed ID: 21670458
    [No Abstract]   [Full Text] [Related]  

  • 20. Management of testicular seminoma advanced disease. Report on 14 cases and review of the literature.
    Porcaro AB; Antoniolli SZ; Maffei N; Beltrami P; Bassetto MA; Curti P
    Arch Ital Urol Androl; 2002 Jun; 74(2):81-5. PubMed ID: 12161942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.